Ask the internet whether cannabis "works" and you'll get two loud answers: miracle and menace. The research says something quieter and more useful. Here is what the strongest reviews actually found — with the receipts.
The short answer
Evidence strength depends entirely on what you ask about. For chronic pain, it is genuinely strong. For chemotherapy-related nausea and MS-related muscle stiffness, respectable. For sleep, modest. For anxiety, depression and most mental-health uses — despite what half of Instagram will tell you — it is thin. Anyone who flattens that picture, in either direction, is selling something.
Where the evidence is strong
The most comprehensive review ever conducted — the U.S. National Academies of Sciences' 2017 report, which weighed over 10,000 studies — put it plainly:
"There is conclusive or substantial evidence that cannabis or cannabinoids are effective for the treatment of chronic pain in adults."
— NASEM, The Health Effects of Cannabis and Cannabinoids, 2017
The same report found substantial evidence for chemotherapy-induced nausea and vomiting, and moderate evidence for multiple-sclerosis spasticity. Note the word choices — effective is not the same as dramatic. Benefits in trials are typically modest, and responses vary a great deal between individuals. Our pain evidence page goes deeper.
Where it is honest to say "we don't know yet"
In 2019, researchers pooled 83 studies covering nearly 3,500 people for The Lancet Psychiatry — the largest look at cannabinoids and mental health to date. Their conclusion:
"There is scarce evidence to suggest that cannabinoids improve depressive disorders and symptoms, anxiety disorders, attention-deficit hyperactivity disorder, Tourette syndrome, post-traumatic stress disorder, or psychosis."
— Black et al., The Lancet Psychiatry, 2019
"Scarce" is not "zero" — research continues, and some people report short-term calm. But nobody honest can promise mental-health results today. We keep our own stress and mood pages updated with exactly this framing.
What about safety?
The World Health Organization's expert committee reviewed cannabidiol in 2018 and found that "CBD is generally well tolerated with a good safety profile," adding that reported adverse effects were often the result of interactions with patients' existing medications — which is precisely why a doctor should know everything you take. The risks that are real — drowsiness, dependency in some users, psychiatric effects in susceptible people, driving impairment — are catalogued honestly in our safety guide.
How to read cannabis research yourself
Three habits will make you sharper than most of the internet:
- Prefer reviews over single studies. One exciting trial means little; NASEM-style syntheses of hundreds mean a lot.
- Watch the language. "Conclusive," "moderate," "limited," "insufficient" — these words are chosen carefully. Marketing removes them; science keeps them.
- Check who benefits. A brand quoting only the favourable half of a review is answering a different question than you are asking.
That, in one paragraph, is our whole philosophy: Questions Before Conclusions. Start at the Education Center if you want the full tour — or the plain-language FAQ if you just want your questions answered.
Sources
- NASEM (2017), The Health Effects of Cannabis and Cannabinoids — full report
- Black et al. (2019), The Lancet Psychiatry — cannabinoids and mental disorders
- WHO Expert Committee on Drug Dependence (2018) — Cannabidiol Critical Review
- Abrams (2018) — update on the NASEM report, Eur. J. Internal Medicine
Educational content, not medical advice. Individual responses vary; consult a qualified doctor. For responsible adults (18+).